MarketPeel
Insider Trading Intelligence
RC

Robert Carey

XAIR
DIRECTOR · BEYOND AIR, INC. · CIK 0001602064
FILING MIX · LIFETIME86%/14%
BUYS
75
SELLS
12
TOTAL VALUE
$10.32M
COMPANIES
2
ACTIVE SINCE
May 2020
HOLDINGS NOW
99,600
AVG SELL PX
TRADE KIND
SHOWING 87 / 87
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
39 backtested trades · 8 horizons · 7 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Robert Carey, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d39+71.79%+7.31%+0.64%+6.67%+2.13%3.45
14d39+51.28%+1.51%+0.98%+0.53%-1.23%0.30
30d39+48.72%-2.31%-0.27%-2.04%-1.78%-1.05
60d39+48.72%-0.80%+1.44%-2.24%-3.45%-0.57
90d39+38.46%-6.49%+2.50%-8.99%-10.95%-2.00
180d39+33.33%-10.48%+5.51%-15.99%-17.90%-2.50
1y39+23.08%-41.44%+15.64%-57.08%-83.94%-7.17
2y39(7 pending)+21.88%-51.51%+32.81%-84.32%-117.05%-6.08
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
XAIR · 0 shares · as of Nov 4, 2025
02,471,6584,943,3177,414,9759,886,63320212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 75 buys / 12 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
5050Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
4,5004,500Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
SALE
4,5000Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
SALE
500Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
1,5001,500Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
SALE
1,5000Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
1,2501,250Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
10,00010,000Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
2,0002,000Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
SALE
2,0000Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
SALE
1,2500Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
SALE
10,0000Nov 4, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
PURCHASE
512,821512,821Nov 3, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
494,332494,332Nov 3, 2025Nov 7, 2025View →
XAIR
BEYOND AIR, INC.
SALE
494,3320Nov 3, 2025Nov 7, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
50,00050,000Jun 12, 2025Jun 16, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
25,00099,600Jun 12, 2025Jun 16, 2025View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
200,000200,000Mar 26, 2025Mar 28, 2025View →
XAIR
BEYOND AIR, INC.
PURCHASE
990,000$0.25$247.5K4,066,864Mar 14, 2025Mar 17, 2025View →
XAIR
BEYOND AIR, INC.
PURCHASE
10,000$0.26$2.5K4,076,864Mar 14, 2025Mar 17, 2025View →
XAIR
BEYOND AIR, INC.
SALE
30,0000Nov 22, 2024Nov 26, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
30,00030,000Nov 22, 2024Nov 26, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
40,00040,000Nov 22, 2024Nov 26, 2024View →
XAIR
BEYOND AIR, INC.
SALE
1,0000Nov 22, 2024Nov 26, 2024View →
XAIR
BEYOND AIR, INC.
SALE
90,0000Nov 22, 2024Nov 26, 2024View →
XAIR
BEYOND AIR, INC.
SALE
25,0000Nov 22, 2024Nov 26, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
25,00025,000Nov 22, 2024Nov 26, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
90,00090,000Nov 22, 2024Nov 26, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
1,0001,000Nov 22, 2024Nov 26, 2024View →
XAIR
BEYOND AIR, INC.
SALE
40,0000Nov 22, 2024Nov 26, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASE
9,886,6339,886,633Sep 27, 2024Oct 1, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASE
1,476,626$0.50$744.7K1,476,626Sep 26, 2024Oct 1, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASE
26,14226,142Sep 26, 2024Oct 1, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASE
1,880,5651,880,565Sep 26, 2024Oct 1, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASE
102,382102,382Sep 26, 2024Oct 1, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASE
480,179480,179Sep 26, 2024Oct 1, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASE
100,000$0.40$39.7K3,076,864Aug 14, 2024Aug 15, 2024View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
50,00050,000Jun 4, 2024Jun 6, 2024View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
25,00074,600Jun 4, 2024Jun 6, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
602,410$1.66$1.00M2,976,864Mar 20, 2024Mar 21, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
602,410602,410Mar 20, 2024Mar 21, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
90,00090,000Mar 20, 2024Mar 21, 2024View →
XAIR
BEYOND AIR, INC.
PURCHASE
1,200,000$1.64$1.96M2,374,454Dec 18, 2023Dec 19, 2023View →
XAIR
BEYOND AIR, INC.
PURCHASE
250,000$2.70$673.8K1,225,160Aug 28, 2023Aug 29, 2023View →
XAIR
BEYOND AIR, INC.
PURCHASE
75,050$2.76$207.5K975,160Aug 21, 2023Aug 22, 2023View →
XAIR
BEYOND AIR, INC.
PURCHASE
13,614$2.64$35.9K900,110Aug 18, 2023Aug 22, 2023View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
27,75027,750Jun 1, 2023Jun 5, 2023View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
13,90049,600Jun 1, 2023Jun 5, 2023View →
XAIR
BEYOND AIR, INC.
PURCHASE
10,000$6.45$64.5K886,496Mar 30, 2023Mar 30, 2023View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
40,00040,000Mar 29, 2023Mar 31, 2023View →
XAIR
BEYOND AIR, INC.
PURCHASE
10,000$6.30$63.0K876,496Mar 29, 2023Mar 30, 2023View →
XAIR
BEYOND AIR, INC.
PURCHASE
10,000$6.85$68.5K866,496Mar 14, 2023Mar 15, 2023View →
XAIR
BEYOND AIR, INC.
PURCHASE
4,173$6.15$25.7K856,496Mar 13, 2023Mar 15, 2023View →
XAIR
BEYOND AIR, INC.
PURCHASE
10,000$5.95$59.5K852,323Mar 8, 2023Mar 9, 2023View →
XAIR
BEYOND AIR, INC.
PURCHASE
20,000$5.75$115.0K842,323Dec 7, 2022Dec 9, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASE
15,000$5.75$86.2K822,323Nov 29, 2022Nov 30, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASE
15,000$5.75$86.2K807,323Nov 28, 2022Nov 30, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASE
20,000$5.80$116.0K792,323Nov 18, 2022Nov 18, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASE
20,000$5.90$118.0K772,323Nov 17, 2022Nov 18, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASE
10,000$6.00$60.0K752,323Nov 16, 2022Nov 18, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASE
175,000$6.45$1.13M742,323Jun 30, 2022Jul 5, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASE
20,000$6.71$134.2K567,323Apr 5, 2022Apr 6, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASE
22,500$6.65$149.6K547,323Mar 25, 2022Mar 28, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASE
3,685$6.58$24.2K524,823Mar 24, 2022Mar 28, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASE
20,000$6.75$135.0K521,138Mar 17, 2022Mar 21, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
30,00030,000Mar 3, 2022Mar 7, 2022View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
25,00025,000Feb 25, 2022Mar 1, 2022View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
12,50035,700Feb 25, 2022Mar 1, 2022View →
XAIR
BEYOND AIR, INC.
PURCHASE
10,000$9.50$95.0K518,418Dec 22, 2021Dec 27, 2021View →
XAIR
BEYOND AIR, INC.
PURCHASE
5,000$12.35$61.8K508,418Nov 23, 2021Nov 26, 2021View →
XAIR
BEYOND AIR, INC.
PURCHASE
10,000$12.05$120.5K503,418Nov 22, 2021Nov 24, 2021View →
XAIR
BEYOND AIR, INC.
PURCHASE
12,000$14.10$169.2K493,418Nov 19, 2021Nov 23, 2021View →
XAIR
BEYOND AIR, INC.
PURCHASE
350,000$5.36$1.88M481,418Jun 17, 2021Jun 21, 2021View →
XAIR
BEYOND AIR, INC.
PURCHASEGRANT
Stock grant
25,00025,000Mar 4, 2021Mar 8, 2021View →
XAIR
BEYOND AIR, INC.
PURCHASE
17,000$5.70$96.9K131,418Mar 4, 2021Mar 5, 2021View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
16,40016,400Feb 25, 2021Mar 1, 2021View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
8,20023,200Feb 25, 2021Mar 1, 2021View →
XAIR
BEYOND AIR, INC.
PURCHASE
15,000$6.67$100.0K114,418Feb 18, 2021Feb 18, 2021View →
XAIR
BEYOND AIR, INC.
PURCHASE
10,000$5.70$57.0K99,418Aug 24, 2020Aug 26, 2020View →
XAIR
BEYOND AIR, INC.
PURCHASE
50,000$5.65$282.5K89,418Aug 14, 2020Aug 18, 2020View →
XAIR
BEYOND AIR, INC.
PURCHASE
10,000$5.50$55.0K39,418Aug 14, 2020Aug 18, 2020View →
XAIR
BEYOND AIR, INC.
PURCHASE
5,000$5.45$27.3K24,418Aug 13, 2020Aug 17, 2020View →
XAIR
BEYOND AIR, INC.
PURCHASE
5,000$5.30$26.5K29,418Aug 13, 2020Aug 17, 2020View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
2,5007,500May 18, 2020May 20, 2020View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
15,00015,000May 18, 2020May 20, 2020View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
20,00020,000May 18, 2020Jun 3, 2020View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
10,00015,000May 18, 2020Jun 3, 2020View →
Other insiders · XAIR
Loading peer insiders…
About this filer
CIK 0001602064
ROLE
Director
PRIMARY
XAIR
COMPANIES
2
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001602064DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback